BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15378272)

  • 1. cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.
    Samimi G; Manorek G; Castel R; Breaux JK; Cheng TC; Berry CC; Los G; Howell SB
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):1-11. PubMed ID: 15378272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells.
    Cheng TC; Manorek G; Samimi G; Lin X; Berry CC; Howell SB
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):384-95. PubMed ID: 16404635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
    Tang H; Liu YJ; Liu M; Li X
    Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.
    Kashiwagi E; Izumi H; Yasuniwa Y; Baba R; Doi Y; Kidani A; Arao T; Nishio K; Naito S; Kohno K
    Cancer Sci; 2011 Feb; 102(2):382-6. PubMed ID: 21087353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.
    Duan Z; Lamendola DE; Duan Y; Yusuf RZ; Seiden MV
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):277-85. PubMed ID: 15565326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.
    Stordal B; Peters G; Davey R
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1094-105. PubMed ID: 16967470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.
    Duale N; Lindeman B; Komada M; Olsen AK; Andreassen A; Soderlund EJ; Brunborg G
    Mol Cancer; 2007 Aug; 6():53. PubMed ID: 17711579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.
    Duan Z; Feller AJ; Penson RT; Chabner BA; Seiden MV
    Clin Cancer Res; 1999 Nov; 5(11):3445-53. PubMed ID: 10589757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
    Goto T; Takano M; Sakamoto M; Kondo A; Hirata J; Kita T; Tsuda H; Tenjin Y; Kikuchi Y
    Oncol Rep; 2006 May; 15(5):1265-71. PubMed ID: 16596196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells.
    Varma R; Hector S; Greco WR; Clark K; Hawthorn L; Porter C; Pendyala L
    Cancer Chemother Pharmacol; 2007 May; 59(6):711-23. PubMed ID: 17021820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture.
    Helleman J; Smid M; Jansen MP; van der Burg ME; Berns EM
    Gynecol Oncol; 2010 May; 117(2):170-6. PubMed ID: 20132968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
    Meynard D; Le Morvan V; Bonnet J; Robert J
    Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK; Davey MW; Davey RA
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.
    Maxwell PJ; Longley DB; Latif T; Boyer J; Allen W; Lynch M; McDermott U; Harkin DP; Allegra CJ; Johnston PG
    Cancer Res; 2003 Aug; 63(15):4602-6. PubMed ID: 12907638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.
    Watson MB; Lind MJ; Smith L; Drew PJ; Cawkwell L
    Acta Oncol; 2007; 46(5):651-8. PubMed ID: 17562441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross platform microarray analysis for robust identification of differentially expressed genes.
    Bosotti R; Locatelli G; Healy S; Scacheri E; Sartori L; Mercurio C; Calogero R; Isacchi A
    BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S5. PubMed ID: 17430572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.